Certain Philips Respironics DreamStation breathing devices, commonly used for treating sleep apnea, may deliver the incorrect prescription or no therapy at all, the FDA warned in a recall announcement ...

In a classic “two steps forward, one step back” situation, just as Philips is aiming to wrap up the repair-and-replace program for the 5.5 million respiratory devices it began recalling two years ago, ...

Earlier this week, the U.S. Department of Justice, representing the Food and Drug Administration and healthcare technology company Philips came to an agreement to no longer sell their sleep therapy or ...

Three years after one of the largest medical device recalls in history, the fallout – health-wise and financial – continues to impact many patients with sleep apnea. Now a critical deadline is ...

Medical device company Philips reached a settlement Monday to shell out $1.1 billion to cover hundreds of personal injury lawsuits linked to its respiration and sleep apnea machines. The manufacturer ...

One of the nation's largest makers of machines for sleep apnea sufferers has agreed to pay at least $479 million to compensate customers who bought the devices. Philips Respironics and Koninklijke ...

On Friday, the Food and Drug Administration issued a Class I recall for certain Philips CPAP and BiPAP respirators that were refurbished in an earlier recall, the latest in a string of troubles for ...

The US Food and Drug Administration issued a Class I recall Friday, the most serious type of recall, for certain Philips Respironics DreamStation1 CPAP machines. A Class I recall means the FDA has ...

Philips DreamStation 2 continuous positive airway pressure (CPAP) machines should be monitored for signs of overheating, according to the Food and Drug Administration (FDA). The Philips DreamStation 2 ...